BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31280221)

  • 1. Using Image-guided Intensity-modulated Radiotherapy on Patients With Head and Neck Soft-tissue Sarcoma.
    Elsayad K; Stockmann D; Channaoui M; Scobioala S; Grajda A; Berssenbrügge H; Huss S; Moustakis C; Haverkamp U; Kleinheinz J; Lenz G; Wardelmann E; Eich HT
    In Vivo; 2019; 33(4):1293-1300. PubMed ID: 31280221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensity-modulated Radiotherapy in Patients With Aggressive Extranodal Non-Hodgkin Lymphoma of the Head and Neck.
    Eismann J; Elsayad K; Rolf D; Sarif I; Wardelmann E; Berssenbrügge H; Lenz G; Eich HT
    Anticancer Res; 2021 Oct; 41(10):5131-5135. PubMed ID: 34593464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involved-site image-guided intensity modulated versus 3D conformal radiation therapy in early stage supradiaphragmatic Hodgkin lymphoma.
    Filippi AR; Ciammella P; Piva C; Ragona R; Botto B; Gavarotti P; Merli F; Vitolo U; Iotti C; Ricardi U
    Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):370-5. PubMed ID: 24613810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective comparison of outcome and toxicity of preoperative image-guided intensity-modulated radiotherapy versus conventional pelvic radiotherapy for locally advanced rectal carcinoma.
    Huang CM; Huang MY; Tsai HL; Huang CW; Ma CJ; Lin CH; Huang CJ; Wang JY
    J Radiat Res; 2017 Mar; 58(2):247-259. PubMed ID: 27738080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of intensity-modulated radiotherapy versus conventional radiotherapy for hypopharyngeal cancer.
    Mok G; Gauthier I; Jiang H; Huang SH; Chan K; Witterick IJ; O'Sullivan B; Waldron JN; Bayley AJ; Cho BC; Cummings BJ; Dawson LA; Hope AJ; Kim JJ; Ringash J
    Head Neck; 2015 May; 37(5):655-61. PubMed ID: 24590756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Image-Guided Intensity-Modulated Radiotherapy and Low-dose Rate Brachytherapy with or without External Beam Radiotherapy in Patients with Localized Prostate Cancer.
    Tsubokura T; Yamazaki H; Masui K; Sasaki N; Shimizu D; Suzuki G; Nakamura S; Yamada K; Okihara K; Shiraishi T; Yoshida K; Nishikawa T; Okabe H
    Sci Rep; 2018 Jul; 8(1):10538. PubMed ID: 30002393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypopharyngeal squamous cell carcinoma: Three-dimensional or Intensity-modulated radiotherapy? A single institution's experience.
    Katsoulakis E; Riaz N; Hu M; Morris L; Sherman E; McBride S; Lee N
    Laryngoscope; 2016 Mar; 126(3):620-6. PubMed ID: 26597398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late Toxicity After Adjuvant Conventional Radiation Versus Image-Guided Intensity-Modulated Radiotherapy for Cervical Cancer (PARCER): A Randomized Controlled Trial.
    Chopra S; Gupta S; Kannan S; Dora T; Engineer R; Mangaj A; Maheshwari A; Shylasree TS; Ghosh J; Paul SN; Phurailatpam R; Charnalia M; Alone M; Swamidas J; Mahantshetty U; Deodhar K; Kerkar R; Shrivastava SK
    J Clin Oncol; 2021 Nov; 39(33):3682-3692. PubMed ID: 34506246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locoregional Control and Toxicity in Head and Neck Carcinoma Patients following Helical Tomotherapy-Delivered Intensity-Modulated Radiation Therapy Compared with 3D-CRT Data.
    Santa Cruz O; Tsoutsou P; Castella C; Khanfir K; Anchisi S; Bouayed S; Matzinger O; Ozsahin M
    Oncology; 2018; 95(2):61-68. PubMed ID: 29895020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the planning target volume in the treatment of head and neck cancer with intensity-modulated radiotherapy: what is the appropriate expansion margin in the setting of daily image guidance?
    Chen AM; Farwell DG; Luu Q; Donald PJ; Perks J; Purdy JA
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):943-9. PubMed ID: 20932680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of daily versus nondaily image-guided radiotherapy protocols for patients treated with intensity-modulated radiotherapy for head and neck cancer.
    Yu Y; Michaud AL; Sreeraman R; Liu T; Purdy JA; Chen AM
    Head Neck; 2014 Jul; 36(7):992-7. PubMed ID: 23780718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of image guidance on toxicity and tumour outcome in moderately hypofractionated external-beam radiotherapy for prostate cancer.
    Jereczek-Fossa BA; Maucieri A; Marvaso G; Gandini S; Fodor C; Zerini D; Riva G; Alessandro O; Surgo A; Volpe S; Fanetti G; Arculeo S; Zerella MA; Parisi S; Maisonneuve P; Vavassori A; Cattani F; Cambria R; Garibaldi C; Starzyńska A; Musi G; De Cobelli O; Ferro M; Nolè F; Ciardo D; Orecchia R
    Med Oncol; 2018 Nov; 36(1):9. PubMed ID: 30483899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of CT-guided
    Chen Y; Jiang Y; Ji Z; Jiang P; Xu F; Zhang Y; Guo F; Peng R; Li X; Sun H; Lei R; Fan J; Li W; Wang J
    Brachytherapy; 2020; 19(1):81-89. PubMed ID: 31653566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pelvic bone anatomy vs implanted gold seed marker registration for image-guided intensity modulated radiotherapy for prostate carcinoma: Comparative analysis of inter-fraction motion and toxicities.
    Rastogi M; Nanda SS; Gandhi AK; Dalela D; Khurana R; Mishra SP; Srivastava A; Farzana S; Bhatt MLB; Husain N
    J Egypt Natl Canc Inst; 2017 Dec; 29(4):185-190. PubMed ID: 29129577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity-modulated radiotherapy in patients with head and neck cancer: a European single-centre experience.
    Van Gestel D; Van Den Weyngaert D; Schrijvers D; Weyler J; Vermorken JB
    Br J Radiol; 2011 Apr; 84(1000):367-74. PubMed ID: 21415302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiotherapy as Part of Treatment Strategies in Nasal Cavity and Paranasal Sinus Malignancies.
    Owin N; Elsayad K; Rolf D; Haverkamp U; Suwelack D; Tschakert R; Berssenbrugge H; Kleinheinz J; Rudack C; Eich HT
    Anticancer Res; 2021 Mar; 41(3):1587-1592. PubMed ID: 33788753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of outcome and toxicity of postoperative intensity-modulated radiation therapy with two-dimensional radiotherapy in patients with soft tissue sarcoma of extremities and trunk.
    Wang J; Song Y; Liu X; Jin J; Wang W; Yu Z; Liu Y; Li N; Fang H; Ren H; Tang Y; Tang Y; Chen B; Lu N; Qi S; Wang S; Li Y
    Cancer Med; 2019 Mar; 8(3):902-909. PubMed ID: 30740916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation-induced optic neuropathy after stereotactic and image guided intensity-modulated radiation therapy (IMRT).
    Brecht S; Boda-Heggemann J; Budjan J; Siebenlist K; Stieler F; Steil V; Wenz F; Lohr F; Buergy D
    Radiother Oncol; 2019 May; 134():166-177. PubMed ID: 31005211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs of care in a matched pair comparison of intensity-modulated radiation therapy (IMRT) versus conventional radiation therapy (CRT) for the treatment of head and neck cancer.
    Sheets NC; Wheeler SB; Kohler RE; Fried DV; Brown PM; Chera BS
    Am J Clin Oncol; 2014 Dec; 37(6):539-44. PubMed ID: 23466583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute toxicity after image-guided intensity modulated radiation therapy compared to 3D conformal radiation therapy in prostate cancer patients.
    Wortel RC; Incrocci L; Pos FJ; Lebesque JV; Witte MG; van der Heide UA; van Herk M; Heemsbergen WD
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):737-44. PubMed ID: 25752386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.